Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)

Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Trial Optional)

National Institutes of Health (NIH)

The National Institute on Drug Abuse (NIDA) seeks to accelerate the development of medication for the treatment of Substance Use Disorders (SUDs) by encouraging research applications to support a diverse array of preclinical and/or clinical research projects. The goal is to fund medication studies that will have high impact and quickly yield the necessary results to advance medications closer to FDA approval.

DEADLINE : Applications will be accepted on a rolling basis, beginning on September 3, 2022.

Arua Coe-NCD grants and funding logo

Leave a Reply

Your email address will not be published. Required fields are marked *